WATSON 152 8 mg Pill - white capsule/oblong, 19mm
Generic Name: silodosin
Pill with imprint WATSON 152 8 mg is White, Capsule/Oblong and has been identified as Rapaflo 8 mg. It is supplied by Allergan, Inc.
Rapaflo is used in the treatment of Benign Prostatic Hyperplasia and belongs to the drug class alpha blockers. There is no proven risk in humans during pregnancy. Rapaflo 8 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for WATSON 152 8 mg
Rapaflo
- Generic Name
- silodosin
- Imprint
- WATSON 152 8 mg
- Strength
- 8 mg
- Color
- White
- Size
- 19.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Alpha blockers
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Allergan, Inc.
- National Drug Code (NDC)
- 52544-0152 (Discontinued)
More about Rapaflo (silodosin)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (99)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Generic availability
- FDA approval history
- Drug class: alpha blockers
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
